385
Views
2
CrossRef citations to date
0
Altmetric
Review

Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present)

, , , & ORCID Icon
Pages 1097-1122 | Received 05 Jan 2022, Accepted 27 Sep 2022, Published online: 14 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jelena Colic, Corrado Campochiaro, Michael Hughes, Marco Matucci Cerinic & Lorenzo Dagna. (2023) Investigational drugs for the treatment of scleroderma: what’s new?. Expert Opinion on Investigational Drugs 32:7, pages 601-614.
Read now

Articles from other publishers (1)

Ling Gao, Li Peng, Prativa Sherchan, Hong Tang, Yu Liu, Jie Xiao, Hui Shi, Yujie Luo, Jiping Tang, John H. Zhang & Ying Xia. (2023) Inhibition of lysophosphatidic acid receptor 1 relieves PMN recruitment in CNS via LPA1/TSP1/CXCR2 pathway and alleviates disruption on blood-brain barrier following intracerebral haemorrhage in mice. Fluids and Barriers of the CNS 20:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.